Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systems
与血管、肺和血液系统病理生理学相关的信号传导机制和功能
基本信息
- 批准号:9244290
- 负责人:
- 金额:$ 91.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adult Respiratory Distress SyndromeApplications GrantsBiochemicalBiologicalBloodBlood VesselsCRISPR/Cas technologyCell PolarityCell membraneCell-Matrix JunctionCellsChemicalsChemotactic FactorsDiseaseExocytosisFibroblastsFunctional disorderFundingFunding MechanismsG-Protein-Coupled ReceptorsGenomicsHeartIn VitroLaboratoriesLungMediatingMissionMolecularNADPH OxidasePathogenicityPathway interactionsPhysiologicalProcessProteomicsPulmonary FibrosisRNA InterferenceReadinessRegulationResearchResearch Project GrantsSignal PathwaySignal TransductionSystemTechnologyTestingTherapeuticTransgenic OrganismsWnt proteinsbasefallsflexibilityfunctional genomicshigh rewardhigh riskin vivoinnovationinsightinterestmigrationnovelreceptorsuccesstherapeutic target
项目摘要
Project Summary:
My laboratory is interested in understanding molecular basis and functions for two signaling
pathways that use seven transmembrane receptors in their signaling transduction. One of the
pathways is mediated by G protein-coupled receptors, and the other is activated by Wnt
proteins. We have been using a combination of biochemical, molecular and cell biological,
transgenic, genomic, proteomic, structural and chemical biological approaches to discover novel
signaling mechanisms and investigate their functions in vitro and in vivo. In this R35 application,
I intend to streamline our current four research projects that are pertinent to NHBLI missions
under one funding mechanism. Two of the projects are current funded by NHBLI. These four
projects are: 1) To test the hypothesis that the initial break of the symmetry may arise from PM
PI4P polarization caused by plasma membrane deformation as the result of cell attachment.
Polarized PM PI4P defines the “uropod” and thus the initial cellular polarity, upon which further
polarization stimulated by chemoattractants is extended. 2) To investigate the sustained
signaling pathway for regulation of fibroblast migration and its therapeutic potential in treating
pulmonary fibrosis. 3) To Investigate the hypothesis that increased exocytosis is a pathogenic
basis for CCM disease. 4) To investigate MEKK3 as being a negative regulator of NADPH
oxidase 2 (NOD2) and potential therapeutic target for acute respiratory distress syndrome.
Each of the project is highly innovative and would exert a strong impact in their respective field.
In addition, we are generating the new leads coming from these high risk/high reward studies
that include functional genomic screens based on the CRISPR/Cas9 and RNAi technologies.
Thus, this R35 mechanism would not only allow streamlining our grant application and
management so that we can better focus our effort on research, but also afford us the flexibility
to fully and efficiently pursue the new leads coming from these high risk/high reward studies.
Our track record strongly indicates our readiness, capability, and success to pursue subjects
that we deem to be of high-impact even though they fall outside our initial intents.
项目概要:
我的实验室有兴趣了解两种信号传导的分子基础和功能
在信号转导中使用七个跨膜受体的途径之一。
一条通路由G蛋白偶联受体介导,另一条由Wnt激活
我们一直在结合生物化学、分子和细胞生物学,
转基因、基因组、蛋白质组、结构和化学生物学方法来发现新的
信号传导机制并研究其体外和体内功能。
我打算简化我们目前与 NHBLI 任务相关的四个研究项目
其中两个项目目前由 NHBLI 资助。
项目有: 1) 检验对称性的初始破缺可能由 PM 引起的假设
细胞附着导致质膜变形导致 PI4P 极化。
极化 PM PI4P “尾足动物”,从而定义了初始细胞极性,在此基础上进一步
化学引诱剂刺激的极化被延长2)研究持续的。
成纤维细胞迁移调节的信号通路及其治疗潜力
3) 调查胞吐作用增加是致病因素的假设。
4) 研究MEKK3作为NADPH的负调节因子。
氧化酶 2 (NOD2) 和急性呼吸窘迫综合征的潜在治疗靶点。
每个项目都具有高度创新性,并将在各自领域产生强大影响。
此外,我们正在从这些高风险/高回报的研究中产生新的线索
其中包括基于 CRISPR/Cas9 和 RNAi 技术的功能基因组筛选。
因此,这个 R35 机制不仅可以简化我们的拨款申请,
管理使我们能够更好地专注于研究,同时也为我们提供了灵活性
充分有效地寻求来自这些高风险/高回报研究的新线索。
我们的记录有力地表明了我们在追求学科方面的准备、能力和成功
我们认为具有很大影响力,尽管它们不符合我们最初的意图。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dianqing Wu其他文献
Dianqing Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dianqing Wu', 18)}}的其他基金
Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systems
与血管、肺和血液系统病理生理学相关的信号传导机制和功能
- 批准号:
10089468 - 财政年份:2017
- 资助金额:
$ 91.23万 - 项目类别:
Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systems
与血管、肺和血液系统病理生理学相关的信号传导机制和功能
- 批准号:
10570974 - 财政年份:2017
- 资助金额:
$ 91.23万 - 项目类别:
DKK2 regulates NK activation and tumor immunity
DKK2 调节 NK 激活和肿瘤免疫
- 批准号:
10307994 - 财政年份:2017
- 资助金额:
$ 91.23万 - 项目类别:
DKK2 regulates NK activation and tumor immunity
DKK2 调节 NK 激活和肿瘤免疫
- 批准号:
10064071 - 财政年份:2017
- 资助金额:
$ 91.23万 - 项目类别:
Identification of novel genes as being important for neutrophil functions
鉴定对中性粒细胞功能重要的新基因
- 批准号:
8415495 - 财政年份:2012
- 资助金额:
$ 91.23万 - 项目类别:
相似国自然基金
战略研究类:大气学科国家自然科学基金资助布局及其动态变化分析—以2020版申请代码为视角
- 批准号:
- 批准年份:2021
- 资助金额:33 万元
- 项目类别:专项基金项目
中国数学会2009年年会资助申请
- 批准号:10926004
- 批准年份:2009
- 资助金额:15.0 万元
- 项目类别:数学天元基金项目
中药学基础研究现状、资助格局与申请代码的研究
- 批准号:30945203
- 批准年份:2009
- 资助金额:9.0 万元
- 项目类别:专项基金项目
肿瘤学基础研究现状、资助格局与申请代码的研究
- 批准号:30945201
- 批准年份:2009
- 资助金额:8.0 万元
- 项目类别:专项基金项目
模糊数学与系统国际学术研讨会资助申请
- 批准号:10826022
- 批准年份:2008
- 资助金额:4.0 万元
- 项目类别:数学天元基金项目
相似海外基金
Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systems
与血管、肺和血液系统病理生理学相关的信号传导机制和功能
- 批准号:
10089468 - 财政年份:2017
- 资助金额:
$ 91.23万 - 项目类别: